About Us
News
Shop
General Endoscopist
Advanced Endoscopist
Donate
My Account
My Profile
Log Out
Log In
Membership
Why Join
Find a Colleague
Special Interest Groups
International
Master of ASGE
Fellow of ASGE
Join ABE
Trainee Member Resources
Mentorship Program
Diversity, Equity and Inclusion
Education
Industry Training
ARIA Industry Partner
ARIA Graduates
Institute for Training and Technology
Education
Event Calendar
GI Leap: Online Learning
Leadership Development
Clinical
Practice Management
Education for Fellows
International Activities
Featured
ASGE at DDW 2024
Digestibles 2.0
GESAP X
GI Now
Resources
Publications
ASGE Guidelines
Tech Assessments
GIE Journal
VideoGIE
iGIE
Journal Scan
General
COVID-19
IBD
Key Resources
Blog
Artificial Intelligence
Sustainable Endoscopy
Value Of Colonoscopy
Advanced Practice Providers
Additional Resources
Video Tips and Tech Talks
Listen In: GI Endoscopy
Clinical Topics
Patient Materials
Colorectal Cancer Screening Project
For Patients
Find a Doctor
Conditions
Procedures and Treatments
Value of Colonoscopy
Colorectal Cancer Screening
Practice Support
Advocacy
Quality and Safety
GIQuIC
EURP
Payment and Compliance
Practice Solutions
ASGE Guidelines
Home
/
Practice Support
/
Advocacy
Advocacy News Archive
Jul
16
Document link:
ASGE Letter on the Rx Blueprint to Lower Drug Prices
Jun
21
Document link:
ASGE Letter to House Ways and Means on the “Ambulatory Surgical Center Payment Transparency Act of 2018
Feb
06
ASGE Letter to Senate Leadership on Medicare Provisions in CR
Feb
05
ASGE Letter to House Leadership on Medicare Provisions in CR
Jan
02
Document link:
ASGE Letter to CMS on the the QPP Final Rule
Nov
03
CMS Releases 2018 Medicare Payment Rules
Aug
21
Document link:
ASGE responds to proposed policy changes to Quality Payment Program for 2018 performance year
May
23
Document link:
ASGE Letter to United States Senate Health Care Working Group on Healthcare Principles
Jun
13
Document link:
ASGE Comments on the Hospital Inpatient Prospective Payment System Proposed Rule
Jul
05
ASGE Statement Regarding Recent Cochrane Review on Direct Acting Antiviral Therapy for Hepatitis C Virus